Sign up to save your podcasts
Or
Share What's New for the Patient With ER+/HER2- MBC Progressing on CDK 4/6 Inhibitor Therapy? Expert Perspectives on 2023 Updates From San Antonio
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
What's New for the Patient With ER+/HER2- MBC Progressing on CDK 4/6 Inhibitor Therapy? Expert Perspectives on 2023 Updates From San Antonio
Join the experts for recent updates on estrogen receptor-positive (ER+)/HER2-negative (HER2-) metastatic breast cancer (MBC) progressing on cyclin-dependent kinase (CDK) 4/6 inhibitors. Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999406?ecd=bdc_podcast_libsyn_mscpedu
View all episodes
By Medscape Podcasts
4
77 ratings
Join the experts for recent updates on estrogen receptor-positive (ER+)/HER2-negative (HER2-) metastatic breast cancer (MBC) progressing on cyclin-dependent kinase (CDK) 4/6 inhibitors. Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999406?ecd=bdc_podcast_libsyn_mscpedu
More shows like Keeping Current
View all
JAMA Editors' Summary
138 Listeners
The Bob Harrington Show
13 Listeners
NEJM This Week
322 Listeners
Diabetes Core Update
101 Listeners
This Week in Cardiology
886 Listeners
JAMA Clinical Reviews
499 Listeners
One-on-One with Eric Topol
16 Listeners
Mayo Clinic Talks
290 Listeners
The Curbsiders Internal Medicine Podcast
3,331 Listeners
JAMA Medical News
88 Listeners
Core IM | Internal Medicine Podcast
1,145 Listeners
Annals On Call Podcast
189 Listeners
The Clinical Problem Solvers
514 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
366 Listeners
Medicine and the Machine
61 Listeners
Keeping Current CME
25 Listeners
Cardionerds: A Cardiology Podcast
431 Listeners
The Curious Clinicians
373 Listeners